Nutritional targets to enhance exercise performance in chronic obstructive pulmonary disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 6, 2012, Pages 553-560

  Van De Bool, Coby ^a   Steiner, Michael C ^b   Schols, Annemie M W J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

chronic obstructive pulmonary disease; exercise; nutrition; pulmonary rehabilitation; skeletal muscle

Indexed keywords

AMINO ACID; CARBOHYDRATE; CREATINE; GLUTAMIC ACID; GLUTAMINE; POLYUNSATURATED FATTY ACID; PROTEIN; REACTIVE OXYGEN METABOLITE; VITAMIN D;

BODY COMPOSITION; CARBOHYDRATE DIET; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIET SUPPLEMENTATION; EXERCISE; INTRAABDOMINAL FAT; MUSCLE ATROPHY; MYOPATHY; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; OXIDATIVE STRESS; PATIENT CARE; PROTEIN INTAKE; PULMONARY REHABILITATION; REVIEW; TREATMENT PLANNING;

AMINO ACIDS, BRANCHED-CHAIN; ANTIOXIDANTS; BODY COMPOSITION; CHRONIC DISEASE; CREATINE; DIETARY CARBOHYDRATES; DIETARY PROTEINS; DIETARY SUPPLEMENTS; EXERCISE; FATTY ACIDS, UNSATURATED; HUMANS; MUSCLE, SKELETAL; MUSCULAR DISEASES; NUTRITIONAL STATUS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAMIN D;

EID: 84868241279     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328358bdeb     Document Type: Review

References (66)

1. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173:1390-1413.
2. Slinde F, Ellegard L, Gronberg AM, et al. Total energy expenditure in underweight patients with severe chronic obstructive pulmonary disease living at home. Clin Nutr 2003; 22:159-165.
3. Richardson RS, Leek BT, Gavin TP, et al. Reduced mechanical efficiency in chronic obstructive pulmonary disease but normal peak VO2 with small muscle mass exercise. Am J Respir Crit Care Med 2004; 169:89-96.
4. Layec G, Haseler LJ, Hoff J, Richardson RS. Evidence that a higher ATP cost of muscular contraction contributes to the lower mechanical efficiency associated with COPD: preliminary findings. Am J Physiol Regul Integr Comp Physiol 2011; 300:R1142-R1147.
5. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173:79-83.
6. Rutten EP, Breyer MK, Spruit MA, et al. Abdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary disease. Clin Nutr 2010; 29:756-760.
7. Furutate R, Ishii T, Wakabayashi R, et al. Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011; 6:423-430.
8. Van den Borst B, Gosker H, Koster A, et al. The influence of abdominal visceral fat on inflammatory pathways and mortality in obstructive lung disease. Am J Clin Nutr 2012 [Epub ahead of print].
9. Franssen FM, Sauerwein HP, Ackermans MT, et al. Increased postabsorptive and exercise-induced whole-body glucose production in patients with chronic obstructive pulmonary disease. Metabolism 2011; 60:957-964.
10. van den Borst B, Gosker HR, Wesseling G, et al. Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. Am J Clin Nutr 2011; 94:1504-1512.
11. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 2007; 62:944-949.
12. Maltais F, LeBlanc P, Whittom F, et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 2000; 55:848-853.
13. Gosker HR, Hesselink MK, Duimel H, et al. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J 2007; 30:73-79.
14. Steiner MC, Evans R, Deacon SJ, et al. Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease. Thorax 2005; 60:932-936.
15. Gosker HR, Langen RC, Bracke KR, et al. Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure. Am J Respir Cell Mol Biol 2009; 40:710-716.
16. van den Borst B, Koster A, Yu B, et al. Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax 2011; 66:961-969.
17. Bronstad E, Rognmo O, Erik Tjonna A, et al. High intensity knee extensor training restores skeletal muscle function in copd patients. Eur Respir J. 2012.
18. Guzun R, Aguilaniu B, Wuyam B, et al. Effects of training at mild exercise intensities on quadriceps muscle energy metabolism in patients with chronic obstructive pulmonary disease. Acta Physiol (Oxf) 2012; 205:236-246.
19. Vermeeren MA, Wouters EF, Nelissen LH, et al. Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2001; 73:295-301.
20. Remels AH, Gosker HR, Schrauwen P, et al. Peroxisome proliferator- activated receptors: a therapeutic target in COPD? Eur Respir J 2008; 31:502-508.
21. Steiner MC, Barton RL, Singh SJ, Morgan MD. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 2003; 58:745-751.
22. Engelen MP, Deutz NE, Wouters EF, Schols AM. Enhanced levels of wholebody protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162 (4 Pt 1):1488-1492.
23. Kao CC, Hsu JW, Bandi V, et al. Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease. Metabolism 2011; 60:1449-1455.
24. Cuthbertson D, Smith K, Babraj J, et al. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J 2005; 19:422-424.
25. Engelen MP, Wouters EF, Deutz NE, et al. Effects of exercise on amino acid metabolism in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:859-864.
26. Engelen MP, Deutz NE, Mostert R, et al. Response of whole-body protein and urea turnover to exercise differs between patients with chronic obstructive pulmonary disease with and without emphysema. Am J Clin Nutr 2003; 77:868-874.
27. Op den Kamp CM, Langen RC, Haegens A, Schols AM. Muscle atrophy in cachexia: can dietary protein tip the balance? Curr Opin Clin Nutr Metab Care 2009; 12:611-616.
28. Engelen MP, Wouters EF, Deutz NE, et al. Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000; 72:1480-1487.
29. Drummond MJ, Rasmussen BB. Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signalling and human skeletal muscle protein synthesis. Curr Opin Clin Nutr Metab Care 2008; 11:222-226.
30. Haegens A, Schols AM, van Essen AL, et al. Leucine induces myofibrillar protein accretion in cultured skeletal muscle through mTOR dependent and-independent control of myosin heavy chain mRNA levels. Mol Nutr Food Res 2012; 56:741-752.
31. Engelen MP, Schols AM. Altered amino acid metabolism in chronic obstructive pulmonary disease: new therapeutic perspective? Curr Opin Clin Nutr Metab Care 2003; 6:73-78.
32. Rutten EP, Engelen MP, Schols AM, Deutz NE. Skeletal muscle glutamate metabolism in health and disease: state of the art. Curr Opin Clin Nutr Metab Care 2005; 8:41-51.
33. Engelen MP, Schols AM, Does JD, et al. Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. Am J Respir Crit Care Med 2000; 161:98-103.
34. Rutten EP, Franssen FM, Engelen MP, et al. Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2006; 83:829-834.
35. Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr 2012.
36. Baldi S, Aquilani R, Pinna GD, et al. Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia. Int J Chron Obstruct Pulmon Dis 2010; 5:29-39.
37. Engelen MP, Rutten EP, De Castro CL, et al. Supplementation of soy protein with branched-chain amino acids alters protein metabolism in healthy elderly and even more in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2007; 85:431-439.
38. Rutten EP, Engelen MP, Gosker H, et al. Metabolic and functional effects of glutamate intake in patients with chronic obstructive pulmonary disease (COPD). Clin Nutr 2008; 27:408-415.
39. Marwood S, Jack S, Patel M, et al. No effect of glutamine ingestion on indices of oxidative metabolism in stable COPD. Respir Physiol Neurobiol 2011; 177:41-46.
40. Remels AH, Schrauwen P, Broekhuizen R, et al. Peroxisome proliferatoractivated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J 2007; 30:245-252.
41. Remels AH, Gosker HR, Schrauwen P, et al. TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J 2010; 24:5052-5062.
42. KomatsuW, Ishihara K, Murata M, et al. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med 2003; 34:1006-1016.
43. de Batlle J, Sauleda J, Balcells E, et al. Association between Omega3 and Omega6 fatty acid intakes and serum inflammatory markers in COPD. J Nutr Biochem 2011.
44. Suguwara K, Takahashi H, Kashiwagura T, et al. Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD. Respiratory Medicine 2012 e-pub ahead of print July 2012.
45. Broekhuizen R, Wouters EF, Creutzberg EC, et al. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax 2005; 60:376-382.
46. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010; 65:215-220.
47. Zosky GR, Berry LJ, Elliot JG, et al. Vitamin D deficiency causes deficits in lung function and alters lung structure. Am J Respir Crit Care Med 2011; 183:1336-1343.
48. Romme EA, Rutten EP, Smeenk FW, et al. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann Med 2012.
49. Dirks-Naylor AJ, Lennon-Edwards S. The effects of vitamin D on skeletal muscle function and cellular signaling. J Steroid Biochem Mol Biol 2011; 125:159-168.
50. Ceglia L. Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care 2009; 12:628-633.
51. Jackson AS, Shrikrishna D, Kelly JL, et al. Vitamin D and skeletal muscle strength and endurance in chronic obstructive pulmonary disease. Eur Respir J 2012.
52. Stockton KA, Mengersen K, Paratz JD, et al. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 2011; 22:859-871.
53. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012; 156:105-114.
54. Fuld JP, Kilduff LP, Neder JA, et al. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2005; 60:531-537.
55. Deacon SJ, Vincent EE, Greenhaff PL, et al. Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178:233-239.
56. Faager G, Soderlund K, Skold CM, et al. Creatine supplementation and physical training in patients with COPD: a double blind, placebo-controlled study. Int J Chron Obstruct Pulmon Dis 2006; 1:445-453.
57. Al-Ghimlas F, Todd DC. Creatine supplementation for patients with COPD receiving pulmonary rehabilitation: a systematic review and meta-analysis. Respirology 2010; 15:785-795.
58. Barreiro E, Schols AM, Polkey MI, et al. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 2008; 63:100-107.
59. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26:703-719.
60. Gosker HR, Bast A, Haenen GR, et al. Altered antioxidant status in peripheral skeletal muscle of patients with COPD. Respir Med 2005; 99:118-125.
61. Koechlin C, Couillard A, Simar D, et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2004; 169:1022-1027.
62. Laviolette L, Lands LC, Dauletbaev N, et al. Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double-blind pilot study. J Med Food 2010; 13:589-598.
63. van Wetering CR, Hoogendoorn M, Mol SJ, et al. Short-and longterm efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax 2010; 65:7-13.
64. vanWetering CR, Hoogendoorn M, Broekhuizen R, et al. Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial. J Am Med Dir Assoc 2010; 11:179-187.
65. Hoogendoorn M, van Wetering CR, Schols AM, Rutten-van Molken MP. Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Eur Respir J 2010; 35:79-87.
66. Pison CM, Cano NJ, Cherion C, et al. Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial. Thorax 2011; 66:953-960.